Arvada, CO, United States of America

Lloyd Michael Garrick

This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lloyd Michael Garrick. Retrieved from https://idiyas.com/inventor/lloyd-michael-garrick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Lloyd Michael Garrick: Innovator in Hormonal Therapy**

Introduction

Lloyd Michael Garrick, an accomplished inventor based in Arvada, Colorado, has made significant contributions to the field of hormonal therapy. With a focus on therapeutic compounds, Garrick holds a notable patent that showcases his expertise and commitment to innovation in medicine.

Latest Patents

Garrick's patent, titled "Gonadotropin Releasing Hormone Receptor Antagonists," discloses compounds of Formula I that are useful as gonadotropin-releasing hormone (GnRH) receptor antagonists. These compounds have potential applications in managing various medical conditions related to hormone regulation, emphasizing Garrick's role in advancing pharmaceutical science.

Career Highlights

Currently employed at Wyeth, a leading biopharmaceutical company, Garrick has demonstrated a passion for research and development throughout his career. His work at Wyeth contributes to the advancement of therapeutic solutions, particularly in the area of reproductive health and hormone-related therapies.

Collaborations

Garrick has collaborated with notable coworkers, such as Daniel Michael Green and Diane Barbara Hauze. Together, these innovators contribute to a dynamic team environment at Wyeth, fostering creativity and collaboration that drives the development of new therapeutic approaches.

Conclusion

Through his dedication and innovative spirit, Lloyd Michael Garrick continues to make strides in the field of hormonal therapies. His patent reflects the potential benefits of GnRH receptor antagonists, and his collaborative efforts at Wyeth illustrate the importance of teamwork in advancing medical research and developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…